Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS
Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS
Recruiting · NCT05204017 · Registry updated 2026-04-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS | Disease Attributes, Disease Progression, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, frontotemporal dementia, lateral sclerosis, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, progressive muscular atrophy, proteostasis deficiencies, spinal cord disorder, spinal muscular atrophy | Recruiting | Not stated | 2026-04-13 | NCT05204017 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Laval University | 96 |
| McGill University | 81 |
| Simon Fraser University | 18 |
| University of Alberta | 249 |
| University of Toronto | 140 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CHU de Quebec -Universite de Laval | Québec | Canada | 1 |
| McGill University / Montreal Neurological Institute and Hospital | Montreal | Canada | 1 |
| University of Alberta | Edmonton | Canada | 10 |
| University of Toronto / Sunnybrook Health Sciences Centre | Toronto | Canada | 2 |